IRS1 and Insulin resistance: reported that mesenchymal stem cell‐derived sEVs reversed peripheral insulin resistance by restoring insulin receptor substrate 1 (IRS1) and protein kinase B (AKT) phosphorylation (Sun et al. 2018), supporting this mechanism.